Psyence Biomedical Ltd. Gains 48.68%

Mon, Apr 20, 2026 at 07:21 PM

Psyence Biomedical Ltd. (PBM:NASDAQ) soared at $11.3, a gain of 48.7%. On Mon, Apr 20, 2026, PBM:NASDAQ hit a New 2-Week High of $11.3. The stock appeared on our News Catalysts scanner on Mon, Apr 20, 2026 at 09:46 AM in the 'MISCELLANEOUS' category. From Mon, Apr 06, 2026, the stock recorded 70.00% Up Days and 63.64% Green Days

The stock spiked on Mon, Apr 20, 2026 at $16.96 with a volume of 40M+.

About Psyence Biomedical Ltd. (PBM:NASDAQ)

Psyence cultivates natural psilocybin mushrooms (Psilocybe Cubensis) at our federally licensed ISO22000 facility in Southern Africa.

Top 10 Gainers:

Enveric Biosciences, Inc. (ENVB:NASDAQ), 100.55%
Hempacco Co., Inc. (HPCO:NASDAQ), 100%
Theriva Biologics, Inc. (TOVX:NYSEMKT), 59.41%
FGI Industries Ltd. (FGI:NASDAQ), 50.62%
Psyence Biomedical Ltd. (PBM:NASDAQ), 48.68%
Julong Holding Limited (JLHL:NASDAQ), 48.66%
COMPASS Pathways plc (CMPS:NASDAQ), 42.04%
CN Energy Group. Inc. (CNEY:NASDAQ), 41.59%
Beyond Meat, Inc. (BYND:NASDAQ), 41.02%
Cue Biopharma, Inc. (CUE:NASDAQ), 40.15%